Volume | 138,348 |
|
|||||
News | - | ||||||
Day High | 0.0668 | Low High |
|||||
Day Low | 0.035 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Odyssey Group International Inc (QB) | ODYY | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.035 | 0.035 | 0.0668 | 0.0595 | 0.0499 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
19 | 138,348 | US$ 0.04855 | US$ 6,717 | - | 0.021 - 0.235 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:29:49 | 10,000 | US$ 0.0595 | USD |
Odyssey Group International Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 4.70M | 79.07M | - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Odyssey (QB) News
Date | Time | Source | News Article |
---|---|---|---|
6/14/2024 | 16:10 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ODYY Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.03 | 0.07 | 0.03 | 0.0568831 | 92,996 | 0.0295 | 98.33% |
1 Month | 0.0371 | 0.07 | 0.024125 | 0.035743 | 250,730 | 0.0224 | 60.38% |
3 Months | 0.035 | 0.08 | 0.022 | 0.0372908 | 130,082 | 0.0245 | 70.00% |
6 Months | 0.1035 | 0.12 | 0.021 | 0.0510355 | 115,824 | -0.044 | -42.51% |
1 Year | 0.074 | 0.235 | 0.021 | 0.0773163 | 118,767 | -0.0145 | -19.59% |
3 Years | 0.6001 | 0.7998 | 0.021 | 0.1766831 | 93,600 | -0.5406 | -90.08% |
5 Years | 1.75 | 8.00 | 0.021 | 0.3493396 | 85,519 | -1.69 | -96.60% |
Odyssey (QB) Description
Odyssey is a medical company with a focus in the area of life-saving medical solutions. Odyssey's corporate mission is to create, acquire and develop distinct assets, intellectual property, and exceptional technologies that provide meaningful medical solutions. The company is focused on areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity. |